GLUCOCORTICOID-INDUCED OSTEOPOROSIS

被引：2
|
作者：
HAHN, BH
机构：
[1] Univ. of California Sch. of Medicine, Los Angeles, CA
来源：
HOSPITAL PRACTICE | 1995年 / 30卷 / 08期
关键词：
D O I：
10.1080/21548331.1995.11443242
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
High-dose treatment of more than three months' duration reduces bone mass, regardless of the patient's age, sex, or race, Because bone loss is most severe during the first six to 12 months of treatment, prophylaxis to preserve bone-with calcium, vitamin D, a bisphosphonate, and exercise-should begin as soon as the clinical situation permits rather than after the disease has been brought under control.
引用
收藏
页码：45 / &
相关论文
共 50 条
  • [1] Glucocorticoid-induced osteoporosis
    Tamura, Y
    Okinaga, H
    Takami, H
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (09) : 500 - 504
  • [2] Glucocorticoid-induced osteoporosis
    Fine, JB
    Fine, RM
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (05) : 346 - 347
  • [3] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    GENNARI, C
    CLINICAL ENDOCRINOLOGY, 1994, 41 (03) : 273 - 274
  • [4] Glucocorticoid-induced osteoporosis
    Cortet, Bernard
    ANNALES D ENDOCRINOLOGIE, 2023, 84 (03) : 373
  • [5] Glucocorticoid-induced osteoporosis
    Kumar, R
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (05): : 589 - 595
  • [6] Glucocorticoid-induced osteoporosis
    Compston, J
    HORMONE RESEARCH, 2003, 60 : 77 - 79
  • [7] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    LUKERT, BP
    RAISZ, LG
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1994, 20 (03) : 629 - 650
  • [8] Glucocorticoid-induced Osteoporosis
    Lamersdorf, A.
    Siggelkow, H.
    OSTEOLOGIE, 2016, 25 (04) : 269 - 272
  • [9] GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Buttgereit, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 45 - 45
  • [10] Glucocorticoid-Induced Osteoporosis
    Humphrey, Mary B.
    Buckley, Lenore
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (14): : 1378 - 1379
12345